Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1905 | 2433 | 32.1 | 66% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
290 | 3 | PULMONARY EMBOLISM//VENOUS THROMBOEMBOLISM//PULMONARY HYPERTENSION | 41767 |
222 | 2 | VENOUS THROMBOEMBOLISM//DEEP VEIN THROMBOSIS//LOW MOLECULAR WEIGHT HEPARIN | 20551 |
1905 | 1 | LOW MOLECULAR WEIGHT HEPARIN//UNFRACTIONATED HEPARIN//ENOXAPARIN | 2433 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LOW MOLECULAR WEIGHT HEPARIN | authKW | 1112125 | 18% | 20% | 434 |
2 | UNFRACTIONATED HEPARIN | authKW | 324605 | 4% | 25% | 105 |
3 | ENOXAPARIN | authKW | 232710 | 5% | 16% | 113 |
4 | TINZAPARIN | authKW | 183535 | 1% | 46% | 32 |
5 | HEPARIN | authKW | 177843 | 13% | 5% | 311 |
6 | ANTI XA ACTIVITY | authKW | 163370 | 1% | 52% | 25 |
7 | ANTI FACTOR XA ACTIVITY | authKW | 141224 | 1% | 51% | 22 |
8 | DALTEPARIN | authKW | 118743 | 2% | 24% | 40 |
9 | SEMINARS IN THROMBOSIS AND HEMOSTASIS | journal | 118544 | 6% | 6% | 158 |
10 | HAEMOSTASIS | journal | 116137 | 4% | 9% | 107 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 45740 | 42% | 0% | 1016 |
2 | Peripheral Vascular Diseases | 32562 | 34% | 0% | 828 |
3 | Medicine, General & Internal | 2136 | 15% | 0% | 364 |
4 | Pharmacology & Pharmacy | 1206 | 15% | 0% | 370 |
5 | Medical Laboratory Technology | 403 | 2% | 0% | 58 |
6 | Urology & Nephrology | 269 | 4% | 0% | 93 |
7 | Cardiac & Cardiovascular System | 135 | 4% | 0% | 104 |
8 | Critical Care Medicine | 112 | 2% | 0% | 41 |
9 | Respiratory System | 96 | 2% | 0% | 55 |
10 | Transplantation | 75 | 2% | 0% | 38 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | THER EUT ADVISORY SERV | 40154 | 0% | 80% | 4 |
2 | ANTITHROMBOSIS SERV | 26137 | 0% | 42% | 5 |
3 | KRANKENHAUS OTHEKE WABING | 25097 | 0% | 100% | 2 |
4 | BURNABY | 16730 | 0% | 67% | 2 |
5 | ROYAL PATHOLOGISTS | 16730 | 0% | 67% | 2 |
6 | UNITE GERIATR AIGUE | 13379 | 0% | 27% | 4 |
7 | A PROP PATH CLIN THROMBOSIS UNIT | 12549 | 0% | 100% | 1 |
8 | ANGIO BELLARIA | 12549 | 0% | 100% | 1 |
9 | AREA STRATEG PATOL VASCOLARE | 12549 | 0% | 100% | 1 |
10 | BEREICHSLEITER ANGIOL | 12549 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SEMINARS IN THROMBOSIS AND HEMOSTASIS | 118544 | 6% | 6% | 158 |
2 | HAEMOSTASIS | 116137 | 4% | 9% | 107 |
3 | THROMBOSIS RESEARCH | 75406 | 10% | 2% | 248 |
4 | THROMBOSIS AND HAEMOSTASIS | 41613 | 7% | 2% | 182 |
5 | CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS | 19950 | 2% | 3% | 51 |
6 | BLOOD COAGULATION & FIBRINOLYSIS | 8737 | 2% | 1% | 48 |
7 | PHARMACOPEIAL FORUM | 7279 | 0% | 5% | 11 |
8 | JOURNAL OF THROMBOSIS AND THROMBOLYSIS | 6461 | 1% | 2% | 31 |
9 | PHARMACOTHERAPY | 4583 | 2% | 1% | 41 |
10 | NOUVELLE REVUE FRANCAISE D HEMATOLOGIE | 3181 | 1% | 2% | 16 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LOW MOLECULAR WEIGHT HEPARIN | 1112125 | 18% | 20% | 434 | Search LOW+MOLECULAR+WEIGHT+HEPARIN | Search LOW+MOLECULAR+WEIGHT+HEPARIN |
2 | UNFRACTIONATED HEPARIN | 324605 | 4% | 25% | 105 | Search UNFRACTIONATED+HEPARIN | Search UNFRACTIONATED+HEPARIN |
3 | ENOXAPARIN | 232710 | 5% | 16% | 113 | Search ENOXAPARIN | Search ENOXAPARIN |
4 | TINZAPARIN | 183535 | 1% | 46% | 32 | Search TINZAPARIN | Search TINZAPARIN |
5 | HEPARIN | 177843 | 13% | 5% | 311 | Search HEPARIN | Search HEPARIN |
6 | ANTI XA ACTIVITY | 163370 | 1% | 52% | 25 | Search ANTI+XA+ACTIVITY | Search ANTI+XA+ACTIVITY |
7 | ANTI FACTOR XA ACTIVITY | 141224 | 1% | 51% | 22 | Search ANTI+FACTOR+XA+ACTIVITY | Search ANTI+FACTOR+XA+ACTIVITY |
8 | DALTEPARIN | 118743 | 2% | 24% | 40 | Search DALTEPARIN | Search DALTEPARIN |
9 | ANTI FACTOR XA | 91238 | 1% | 36% | 20 | Search ANTI+FACTOR+XA | Search ANTI+FACTOR+XA |
10 | ACTIVATED PARTIAL THROMBOPLASTIN TIME | 78313 | 2% | 15% | 43 | Search ACTIVATED+PARTIAL+THROMBOPLASTIN+TIME | Search ACTIVATED+PARTIAL+THROMBOPLASTIN+TIME |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HIRSH, J , RASCHKE, R , (2004) HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN - THE SEVENTH ACCP CONFERENCE ON ANTITHROMBOTIC AND THROMBOLYTIC THERAPY.CHEST. VOL. 126. ISSUE 3. P. 188S -203S | 106 | 63% | 274 |
2 | HIRSH, J , BAUER, KA , DONATI, MB , GOULD, M , SAMAMA, MM , WEITZ, JI , (2008) PARENTERAL ANTICOAGULANTS.CHEST. VOL. 133. ISSUE 6. P. 141S -159S | 88 | 54% | 274 |
3 | GARCIA, DA , BAGLIN, TP , WEITZ, JI , SAMAMA, MM , (2012) PARENTERAL ANTICOAGULANTS ANTITHROMBOTIC THERAPY AND PREVENTION OF THROMBOSIS, 9TH ED: AMERICAN COLLEGE OF CHEST PHYSICIANS EVIDENCE-BASED CLINICAL PRACTICE GUIDELINES.CHEST. VOL. 141. ISSUE 2. P. E24S -E43S | 90 | 48% | 38 |
4 | HIRSH, J , WARKENTIN, TE , SHAUGHNESSY, SG , ANAND, SS , HALPERIN, JL , RASCHKE, R , GRANGER, C , OHMAN, EM , DALEN, JE , (2001) HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN - MECHANISMS OF ACTION, PHARMACOKINETICS, DOSING, MONITORING, EFFICACY, AND SAFETY.CHEST. VOL. 119. ISSUE 1. P. 64S -94S | 101 | 37% | 523 |
5 | SCHMID, P , FISCHER, AG , WUILLEMIN, WA , (2009) LOW-MOLECULAR-WEIGHT HEPARIN IN PATIENTS WITH RENAL INSUFFICIENCY.SWISS MEDICAL WEEKLY. VOL. 139. ISSUE 31-32. P. 438 -452 | 67 | 68% | 31 |
6 | STRATTA, P , KARVELA, E , CANAVESE, C , QUAGLIA, M , LAZZARICH, E , FENOGLIO, R , PERGOLINI, P , BELLOMO, G , CENA, T , MAGNANI, C , (2009) STRUCTURE-ACTIVITY RELATIONSHIPS OF LOW MOLECULAR WEIGHT HEPARINS EXPOSE TO THE RISK OF ACHIEVING INAPPROPRIATE TARGETS IN PATIENTS WITH RENAL FAILURE.CURRENT MEDICINAL CHEMISTRY. VOL. 16. ISSUE 23. P. 3028-3040 | 58 | 82% | 5 |
7 | SMYTHE, MA , PRIZIOLA, J , DOBESH, PP , WIRTH, D , CUKER, A , WITTKOWSKY, AK , (2016) GUIDANCE FOR THE PRACTICAL MANAGEMENT OF THE HEPARIN ANTICOAGULANTS IN THE TREATMENT OF VENOUS THROMBOEMBOLISM.JOURNAL OF THROMBOSIS AND THROMBOLYSIS. VOL. 41. ISSUE 1. P. 165 -186 | 56 | 62% | 2 |
8 | ERKENS, PMG , PRINS, MH , (2010) FIXED DOSE SUBCUTANEOUS LOW MOLECULAR WEIGHT HEPARINS VERSUS ADJUSTED DOSE UNFRACTIONATED HEPARIN FOR VENOUS THROMBOEMBOLISM.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 9. P. - | 44 | 88% | 28 |
9 | GOUIN-THIBAULT, I , PAUTAS, E , SIGURET, V , (2005) SAFETY PROFILE OF DIFFERENT LOW-MOLECULAR WEIGHT HEPARINS USED AT THERAPEUTIC DOSE.DRUG SAFETY. VOL. 28. ISSUE 4. P. 333-349 | 60 | 75% | 31 |
10 | LIM, W , DENTALI, F , EIKELBOOM, JW , CROWTHER, MA , (2006) META-ANALYSIS: LOW-MOLECULAR-WEIGHT HEPARIN AND BLEEDING IN PATIENTS WITH SEVERE RENAL INSUFFICIENCY.ANNALS OF INTERNAL MEDICINE. VOL. 144. ISSUE 9. P. 673-684 | 40 | 82% | 213 |
Classes with closest relation at Level 1 |